Literature DB >> 25571665

[Hip arthroplasty for the severe comminuted proximal femoral fracture with psilateral acetabulum fracture].

Bo Lü1, Yue Wang, Jian-Xin Zhu, Chong-Xin Huang, Tian-Cheng Liao, An Wang.   

Abstract

OBJECTIVE: To investigate the results of hip arthroplasty for the treatment of severe comminuted proximal femoral fracture with ipsilateral acetabulum fracture.
METHODS: From June 2007 to September 2013, 8 patients (8 hips) with severe comminuted proximal femoral fracture combined with ipsilateral acetabulum fracture were treated with hip arthroplasty. All patients were male and using biological prosthesis. Aged from 33 to 64 years old with an average of 41.9 years. According to Harris score in aspect of pain, function, range of motion to evaluate clinical effects.
RESULTS: There was no untoward reaction in 8 patients. And bed rest at 3 months after operation, waiting for acetabulum fracture healed to out-of-bed activity. There was no complications such as pneumonia, bedsore and so on in the patients. Follow-up time was from 9 to 72 months with an average of 35.8 months, the wound healed, there was no the subsidence and loosening of prosthesis, no dislocation and infection. The mean of Harris score was 87.5 points after operation.
CONCLUSION: The effect of the hip replacement in treating severe comminuted proximal femoral fracture with ipsilateral acetabulum fracture is confirmed. It can restore motor function and reduce traumatic complication, may serve as a substitute for internal fixation of difficult operation. The long-term efficacy is necessary to further observe.

Entities:  

Mesh:

Year:  2014        PMID: 25571665

Source DB:  PubMed          Journal:  Zhongguo Gu Shang        ISSN: 1003-0034


  1 in total

1.  Designation and Validation of a Posterior Anatomical Plate for the Anterior Column of the Acetabulum.

Authors:  Lifeng Zhang; Chuangxin Lin; Shenglu Cao; Yiran Wang; Geng Peng; Yongqiang Xu; Yongzeng Feng; Gang Wang
Journal:  Med Sci Monit       Date:  2017-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.